Skip to main content
KTTA
NASDAQ Life Sciences

Pasithea Therapeutics Expands NF1 Trial Dosing, Extends Treatment Period for PAS-004

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.59
Mkt Cap
$18.712M
52W Low
$0.281
52W High
$2.06
52W Position info
110% above low
Off High info
71% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

KTTA has more than doubled off its 52-week low of $0.281.

Summary

Pasithea Therapeutics has amended the protocol for its Phase 1/1b clinical trial of PAS-004 for NF1, adding higher dose levels up to 32mg and extending the treatment period to 18 months. These changes aim to gather more comprehensive data and optimize dose selection for future registrational studies. The company has already enrolled additional patients in new cohorts and remains on track to release interim NF1 data in Q4 2026. This strategic update strengthens the development path for their lead drug candidate.

At the time of this announcement, KTTA was trading at $0.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18.7M. The 52-week trading range was $0.28 to $2.06. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

KTTA - Latest Insights

KTTA
Nov 03, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3591
Real-time Price: $0.520 info
Change: +$0.1609 (+45%) info
Market Cap: $19.173M info
KTTA
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.520 info
Change: -$0.030 (-5%) info
Market Cap: $19.173M info
KTTA
Sep 09, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5697
Real-time Price: $0.520 info
Change: -$0.0497 (-9%) info
Market Cap: $19.173M info
KTTA
Aug 21, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.490
Real-time Price: $0.520 info
Change: +$0.030 (+6%) info
Market Cap: $19.173M info
KTTA
Jul 29, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4231
Real-time Price: $0.520 info
Change: +$0.0969 (+23%) info
Market Cap: $19.173M info